Gene Symbol | Gene ID | Gene Info |
---|---|---|
Sp100
|
ENSMUSG00000026222.10 | nuclear antigen Sp100 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr1_85668278_85668429 | Sp100 | 3472 | 0.138742 | -0.58 | 3.0e-06 | Click! |
chr1_85716491_85716802 | Sp100 | 13204 | 0.110523 | 0.54 | 2.3e-05 | Click! |
chr1_85649895_85650046 | Sp100 | 18 | 0.907261 | -0.51 | 8.4e-05 | Click! |
chr1_85693391_85693574 | Sp100 | 457 | 0.724753 | -0.49 | 1.6e-04 | Click! |
chr1_85703656_85703861 | Sp100 | 316 | 0.831259 | 0.25 | 6.6e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_112367678_112368469 | 9.61 |
Emc4 |
ER membrane protein complex subunit 4 |
46 |
0.96 |
chr10_29143551_29143727 | 9.20 |
Soga3 |
SOGA family member 3 |
200 |
0.8 |
chr6_77980120_77980374 | 8.77 |
Ctnna2 |
catenin (cadherin associated protein), alpha 2 |
548 |
0.8 |
chr18_35214941_35215148 | 7.74 |
Lrrtm2 |
leucine rich repeat transmembrane neuronal 2 |
20 |
0.56 |
chr4_40948174_40948980 | 6.42 |
Chmp5 |
charged multivesicular body protein 5 |
170 |
0.63 |
chr10_78464271_78465733 | 6.13 |
Pdxk |
pyridoxal (pyridoxine, vitamin B6) kinase |
27 |
0.93 |
chr2_83812214_83812373 | 6.07 |
Fam171b |
family with sequence similarity 171, member B |
343 |
0.86 |
chr19_21742139_21742471 | 5.93 |
Gm50129 |
predicted gene, 50129 |
13035 |
0.2 |
chr15_26308516_26308700 | 5.70 |
Marchf11 |
membrane associated ring-CH-type finger 11 |
440 |
0.9 |
chr19_14776884_14777035 | 5.63 |
Gm26026 |
predicted gene, 26026 |
58479 |
0.15 |
chr8_12481842_12481993 | 5.46 |
Gm33326 |
predicted gene, 33326 |
14953 |
0.16 |
chr3_108423860_108424486 | 5.45 |
Celsr2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
8621 |
0.09 |
chr10_87447758_87448124 | 5.43 |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
45719 |
0.13 |
chr8_23425291_23425763 | 5.39 |
Sfrp1 |
secreted frizzled-related protein 1 |
14025 |
0.25 |
chr9_91456955_91457106 | 5.33 |
Gm29478 |
predicted gene 29478 |
52556 |
0.11 |
chr3_153084641_153085060 | 5.23 |
1700094M23Rik |
RIKEN cDNA 1700094M23 gene |
90560 |
0.07 |
chr15_83998515_83998666 | 5.20 |
Efcab6 |
EF-hand calcium binding domain 6 |
9608 |
0.2 |
chr1_129357494_129357674 | 5.07 |
Gm38330 |
predicted gene, 38330 |
14720 |
0.26 |
chr10_30775683_30775856 | 5.05 |
Ncoa7 |
nuclear receptor coactivator 7 |
3828 |
0.17 |
chr5_112213704_112214228 | 5.03 |
Gm26953 |
predicted gene, 26953 |
1495 |
0.29 |
chr2_48099294_48099480 | 5.02 |
Gm13471 |
predicted gene 13471 |
40759 |
0.22 |
chr5_108549432_108549602 | 5.01 |
Cplx1 |
complexin 1 |
483 |
0.69 |
chr5_73647229_73648112 | 4.99 |
Gm43799 |
predicted gene 43799 |
79 |
0.55 |
chr6_8956269_8957017 | 4.97 |
Nxph1 |
neurexophilin 1 |
6967 |
0.32 |
chr4_142449483_142449665 | 4.97 |
Gm13052 |
predicted gene 13052 |
103099 |
0.07 |
chr13_119462619_119462810 | 4.95 |
4833420G17Rik |
RIKEN cDNA 4833420G17 gene |
54 |
0.96 |
chr2_73775858_73776009 | 4.89 |
Chn1 |
chimerin 1 |
587 |
0.77 |
chr12_103314451_103314805 | 4.85 |
Gm29508 |
predicted gene 29508 |
141 |
0.71 |
chr9_91386515_91386786 | 4.73 |
Zic4 |
zinc finger protein of the cerebellum 4 |
4240 |
0.14 |
chr13_77490089_77490263 | 4.72 |
Gm9634 |
predicted gene 9634 |
64197 |
0.14 |
chr1_15286129_15286280 | 4.67 |
Kcnb2 |
potassium voltage gated channel, Shab-related subfamily, member 2 |
1050 |
0.59 |
chr6_13839580_13839789 | 4.67 |
Gpr85 |
G protein-coupled receptor 85 |
189 |
0.95 |
chr1_9299226_9299428 | 4.61 |
Sntg1 |
syntrophin, gamma 1 |
45 |
0.97 |
chr14_86395608_86395835 | 4.59 |
Gm25115 |
predicted gene, 25115 |
12801 |
0.17 |
chr2_34106829_34107151 | 4.57 |
C230014O12Rik |
RIKEN cDNA C230014O12 gene |
739 |
0.69 |
chr10_3863520_3864007 | 4.57 |
Gm16149 |
predicted gene 16149 |
5844 |
0.21 |
chr4_24430028_24430203 | 4.52 |
Gm27243 |
predicted gene 27243 |
775 |
0.69 |
chr7_44405306_44405805 | 4.47 |
Gm45124 |
predicted gene 45124 |
19155 |
0.06 |
chr7_41500149_41500398 | 4.44 |
AW146154 |
expressed sequence AW146154 |
383 |
0.66 |
chr9_90699218_90699369 | 4.41 |
Gm2497 |
predicted gene 2497 |
34231 |
0.15 |
chr10_118121607_118122166 | 4.41 |
5330439M10Rik |
RIKEN cDNA 5330439M10 gene |
9369 |
0.16 |
chr10_64090435_64090586 | 4.39 |
Lrrtm3 |
leucine rich repeat transmembrane neuronal 3 |
233 |
0.96 |
chr7_87925914_87926440 | 4.38 |
Gm44927 |
predicted gene 44927 |
35428 |
0.2 |
chr3_13946274_13946476 | 4.37 |
Ralyl |
RALY RNA binding protein-like |
18 |
0.99 |
chr2_62807870_62808021 | 4.35 |
Gm13569 |
predicted gene 13569 |
1242 |
0.51 |
chr13_84449354_84449551 | 4.35 |
Gm26927 |
predicted gene, 26927 |
109339 |
0.06 |
chr13_83868824_83869019 | 4.34 |
2810049E08Rik |
RIKEN cDNA 2810049E08 gene |
22287 |
0.18 |
chr2_6882579_6882730 | 4.32 |
Gm13389 |
predicted gene 13389 |
1616 |
0.33 |
chr3_127304308_127304459 | 4.31 |
Gm42970 |
predicted gene 42970 |
4710 |
0.17 |
chr9_18473066_18474201 | 4.30 |
Zfp558 |
zinc finger protein 558 |
74 |
0.95 |
chr2_83940865_83941058 | 4.28 |
Zswim2 |
zinc finger SWIM-type containing 2 |
265 |
0.86 |
chr12_37880645_37881049 | 4.27 |
Dgkb |
diacylglycerol kinase, beta |
131 |
0.98 |
chr18_23040919_23041185 | 4.27 |
Nol4 |
nucleolar protein 4 |
601 |
0.84 |
chr16_67175484_67175665 | 4.24 |
Gm49640 |
predicted gene, 49640 |
62776 |
0.16 |
chr5_42523495_42523716 | 4.23 |
Gm7181 |
predicted gene 7181 |
23191 |
0.28 |
chr6_134208206_134208458 | 4.20 |
Etv6 |
ets variant 6 |
25268 |
0.14 |
chr5_36869434_36869770 | 4.19 |
Ppp2r2c |
protein phosphatase 2, regulatory subunit B, gamma |
939 |
0.5 |
chr2_79459162_79459899 | 4.19 |
Cerkl |
ceramide kinase-like |
2745 |
0.27 |
chr11_54304287_54304643 | 4.14 |
Acsl6 |
acyl-CoA synthetase long-chain family member 6 |
263 |
0.89 |
chr2_10737244_10737438 | 4.13 |
Gm18547 |
predicted gene, 18547 |
156368 |
0.01 |
chr16_77238960_77239248 | 4.10 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
2785 |
0.32 |
chr15_7194818_7195373 | 4.08 |
Egflam |
EGF-like, fibronectin type III and laminin G domains |
27974 |
0.21 |
chr9_42179185_42179358 | 4.07 |
4930546K05Rik |
RIKEN cDNA 4930546K05 gene |
29942 |
0.15 |
chr8_64946989_64947925 | 4.07 |
Tmem192 |
transmembrane protein 192 |
203 |
0.55 |
chr1_132323175_132323364 | 4.05 |
Nuak2 |
NUAK family, SNF1-like kinase, 2 |
4327 |
0.14 |
chr1_66320866_66321435 | 4.05 |
Map2 |
microtubule-associated protein 2 |
569 |
0.75 |
chr3_17326806_17327055 | 4.05 |
Gm30340 |
predicted gene, 30340 |
7495 |
0.24 |
chr2_62047014_62047411 | 4.05 |
Slc4a10 |
solute carrier family 4, sodium bicarbonate cotransporter-like, member 10 |
567 |
0.84 |
chr4_24429061_24429567 | 4.03 |
Gm27243 |
predicted gene 27243 |
1576 |
0.43 |
chr14_75962356_75962507 | 4.02 |
Kctd4 |
potassium channel tetramerisation domain containing 4 |
7422 |
0.18 |
chr2_48423717_48423969 | 4.01 |
Gm13481 |
predicted gene 13481 |
33402 |
0.16 |
chr16_39286894_39287093 | 4.01 |
Gm36742 |
predicted gene, 36742 |
98087 |
0.08 |
chr2_102451171_102452295 | 4.00 |
Fjx1 |
four jointed box 1 |
766 |
0.72 |
chr13_107767262_107767617 | 4.00 |
Zswim6 |
zinc finger SWIM-type containing 6 |
19157 |
0.22 |
chr11_17352189_17352422 | 3.99 |
Gm12015 |
predicted gene 12015 |
53886 |
0.14 |
chr3_105530739_105530942 | 3.94 |
Gm43847 |
predicted gene 43847 |
27933 |
0.18 |
chr6_83572148_83572608 | 3.93 |
Stambp |
STAM binding protein |
39 |
0.96 |
chr3_56955186_56955399 | 3.90 |
Gm22269 |
predicted gene, 22269 |
98858 |
0.08 |
chr8_124140875_124141037 | 3.89 |
Gm3889 |
predicted gene 3889 |
19117 |
0.17 |
chr5_116322637_116322998 | 3.89 |
B230112J18Rik |
RIKEN cDNA B230112J18 gene |
10457 |
0.12 |
chr1_42243884_42244284 | 3.88 |
Gm29664 |
predicted gene 29664 |
5389 |
0.2 |
chr8_97251746_97251906 | 3.88 |
Gm26399 |
predicted gene, 26399 |
4015 |
0.23 |
chr2_84887826_84888036 | 3.85 |
Rtn4rl2 |
reticulon 4 receptor-like 2 |
1221 |
0.36 |
chr8_55034088_55034270 | 3.84 |
Gm45264 |
predicted gene 45264 |
5778 |
0.14 |
chr6_55681745_55681896 | 3.84 |
Neurod6 |
neurogenic differentiation 6 |
557 |
0.78 |
chr2_179481364_179481534 | 3.81 |
Cdh4 |
cadherin 4 |
37216 |
0.18 |
chr10_43173540_43173793 | 3.81 |
Gm29246 |
predicted gene 29246 |
403 |
0.61 |
chr4_148327377_148327851 | 3.81 |
Gm13206 |
predicted gene 13206 |
20761 |
0.14 |
chr1_21960484_21960874 | 3.78 |
Kcnq5 |
potassium voltage-gated channel, subfamily Q, member 5 |
902 |
0.7 |
chr2_53105833_53106109 | 3.77 |
Prpf40a |
pre-mRNA processing factor 40A |
39338 |
0.2 |
chr6_73221281_73221580 | 3.77 |
Dnah6 |
dynein, axonemal, heavy chain 6 |
201 |
0.92 |
chr9_91378900_91379129 | 3.76 |
Zic4 |
zinc finger protein of the cerebellum 4 |
372 |
0.77 |
chr4_23636183_23636497 | 3.76 |
Gm25978 |
predicted gene, 25978 |
9595 |
0.24 |
chr3_108383676_108384374 | 3.76 |
Psrc1 |
proline/serine-rich coiled-coil 1 |
88 |
0.73 |
chrX_7721605_7722047 | 3.70 |
Wdr45 |
WD repeat domain 45 |
147 |
0.74 |
chr2_174918449_174918600 | 3.69 |
Gm14616 |
predicted gene 14616 |
62235 |
0.09 |
chr6_142386279_142386720 | 3.68 |
Recql |
RecQ protein-like |
475 |
0.56 |
chr3_139885937_139886924 | 3.65 |
Gm43678 |
predicted gene 43678 |
73666 |
0.11 |
chr3_9704898_9705332 | 3.64 |
Pag1 |
phosphoprotein associated with glycosphingolipid microdomains 1 |
113 |
0.97 |
chr10_8757305_8757873 | 3.63 |
Sash1 |
SAM and SH3 domain containing 1 |
828 |
0.66 |
chr10_7158653_7159529 | 3.62 |
Cnksr3 |
Cnksr family member 3 |
23585 |
0.24 |
chr8_64691836_64692235 | 3.60 |
Cpe |
carboxypeptidase E |
1019 |
0.52 |
chr13_83722095_83722570 | 3.60 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
951 |
0.46 |
chr4_26929979_26930130 | 3.59 |
Gm11904 |
predicted gene 11904 |
196455 |
0.03 |
chr2_70127698_70127885 | 3.57 |
Myo3b |
myosin IIIB |
31493 |
0.2 |
chr5_37716863_37717819 | 3.57 |
Stk32b |
serine/threonine kinase 32B |
170 |
0.96 |
chr10_115097240_115097417 | 3.55 |
Tph2 |
tryptophan hydroxylase 2 |
78230 |
0.09 |
chr4_5724465_5724747 | 3.54 |
Fam110b |
family with sequence similarity 110, member B |
294 |
0.93 |
chr17_90455921_90456130 | 3.53 |
Nrxn1 |
neurexin I |
75 |
0.96 |
chr13_83744413_83744884 | 3.52 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
5785 |
0.13 |
chrX_157598793_157598972 | 3.50 |
Mbtps2 |
membrane-bound transcription factor peptidase, site 2 |
167 |
0.91 |
chr12_12680284_12680715 | 3.50 |
Gm27952 |
predicted gene, 27952 |
2119 |
0.28 |
chr3_6886780_6886981 | 3.49 |
Gm22074 |
predicted gene, 22074 |
90388 |
0.09 |
chr13_83739197_83739995 | 3.49 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
733 |
0.33 |
chr6_103307293_103307469 | 3.48 |
Gm44295 |
predicted gene, 44295 |
27395 |
0.24 |
chr1_128399169_128399323 | 3.47 |
Dars |
aspartyl-tRNA synthetase |
18113 |
0.16 |
chr2_61656029_61656307 | 3.46 |
Tank |
TRAF family member-associated Nf-kappa B activator |
12337 |
0.22 |
chr12_117805996_117806369 | 3.45 |
Cdca7l |
cell division cycle associated 7 like |
1893 |
0.37 |
chr8_10754564_10754760 | 3.44 |
Gm39129 |
predicted gene, 39129 |
15772 |
0.13 |
chr5_3405118_3405321 | 3.44 |
Cdk6 |
cyclin-dependent kinase 6 |
60907 |
0.09 |
chr2_65833006_65833389 | 3.43 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
12570 |
0.21 |
chr3_69289883_69290176 | 3.43 |
Ppm1l |
protein phosphatase 1 (formerly 2C)-like |
26832 |
0.15 |
chr15_26880673_26880848 | 3.42 |
Fbxl7 |
F-box and leucine-rich repeat protein 7 |
14758 |
0.26 |
chr6_101551112_101551263 | 3.42 |
Gm44171 |
predicted gene, 44171 |
12434 |
0.22 |
chr7_122477682_122477905 | 3.41 |
Gm14389 |
predicted gene 14389 |
6627 |
0.17 |
chr14_101352140_101352621 | 3.41 |
Hspd1-ps5 |
heat shock protein 1 (chaperonin), pseudogene 5 |
8836 |
0.27 |
chr3_116398014_116398356 | 3.40 |
Cdc14a |
CDC14 cell division cycle 14A |
7303 |
0.17 |
chr2_146745615_146745778 | 3.40 |
Gm14111 |
predicted gene 14111 |
10009 |
0.27 |
chr16_77788297_77788506 | 3.39 |
Gm17333 |
predicted gene, 17333 |
58203 |
0.11 |
chr2_146745869_146746069 | 3.38 |
Gm14111 |
predicted gene 14111 |
9736 |
0.27 |
chr2_73385763_73387080 | 3.36 |
Gpr155 |
G protein-coupled receptor 155 |
9 |
0.9 |
chr17_51761383_51761691 | 3.35 |
C230085N15Rik |
RIKEN cDNA C230085N15 gene |
84 |
0.95 |
chr14_15785133_15785550 | 3.35 |
Gm31804 |
predicted gene, 31804 |
11652 |
0.26 |
chr12_56387696_56387852 | 3.34 |
Cox6c2 |
cytochrome c oxidase subunit 6C2 |
13951 |
0.16 |
chr13_15543685_15543865 | 3.34 |
Gli3 |
GLI-Kruppel family member GLI3 |
79795 |
0.08 |
chr3_17793898_17794135 | 3.34 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
71 |
0.96 |
chr8_23596316_23596734 | 3.32 |
Zmat4 |
zinc finger, matrin type 4 |
39494 |
0.19 |
chr4_57955021_57955172 | 3.32 |
Txn1 |
thioredoxin 1 |
1315 |
0.47 |
chr10_39172218_39172477 | 3.31 |
D030034A15Rik |
RIKEN cDNA D030034A15 gene |
905 |
0.5 |
chr8_47243033_47243379 | 3.31 |
Stox2 |
storkhead box 2 |
520 |
0.81 |
chr10_57828634_57829003 | 3.31 |
Smpdl3a |
sphingomyelin phosphodiesterase, acid-like 3A |
34250 |
0.16 |
chr18_50034876_50035293 | 3.30 |
Tnfaip8 |
tumor necrosis factor, alpha-induced protein 8 |
4055 |
0.24 |
chr3_42587434_42587585 | 3.29 |
Gm38044 |
predicted gene, 38044 |
1910 |
0.42 |
chr19_33326930_33327081 | 3.29 |
Rnls |
renalase, FAD-dependent amine oxidase |
65260 |
0.11 |
chr2_49636779_49636930 | 3.29 |
Kif5c |
kinesin family member 5C |
17556 |
0.23 |
chr15_27797878_27798436 | 3.25 |
Trio |
triple functional domain (PTPRF interacting) |
9519 |
0.23 |
chr10_13171046_13171455 | 3.25 |
Zc2hc1b |
zinc finger, C2HC-type containing 1B |
6773 |
0.19 |
chr6_42324738_42325213 | 3.24 |
Fam131b |
family with sequence similarity 131, member B |
332 |
0.77 |
chr2_179537769_179538167 | 3.22 |
Gm14300 |
predicted gene 14300 |
75599 |
0.1 |
chr4_35402797_35403079 | 3.22 |
Gm12368 |
predicted gene 12368 |
1880 |
0.42 |
chr7_73399870_73400476 | 3.22 |
Gm44758 |
predicted gene 44758 |
4177 |
0.15 |
chr4_24019307_24019462 | 3.21 |
Gm28448 |
predicted gene 28448 |
85430 |
0.11 |
chr5_39644263_39645259 | 3.21 |
Hs3st1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 1 |
127 |
0.97 |
chr11_43747463_43748363 | 3.21 |
Ttc1 |
tetratricopeptide repeat domain 1 |
69 |
0.98 |
chr5_37768904_37769238 | 3.20 |
Cytl1 |
cytokine-like 1 |
31791 |
0.15 |
chr12_64965424_64965818 | 3.20 |
Klhl28 |
kelch-like 28 |
87 |
0.63 |
chr6_122495966_122496190 | 3.18 |
Rimklb |
ribosomal modification protein rimK-like family member B |
2683 |
0.18 |
chr6_73315163_73315526 | 3.18 |
Gm44475 |
predicted gene, 44475 |
4703 |
0.23 |
chr10_22579573_22579724 | 3.18 |
Slc2a12 |
solute carrier family 2 (facilitated glucose transporter), member 12 |
65363 |
0.1 |
chr6_55792592_55792989 | 3.17 |
Itprid1 |
ITPR interacting domain containing 1 |
44105 |
0.18 |
chr9_82977066_82977265 | 3.17 |
Phip |
pleckstrin homology domain interacting protein |
1649 |
0.41 |
chr3_34838105_34838267 | 3.15 |
Gm21388 |
predicted gene, 21388 |
1036 |
0.6 |
chr11_16257459_16258097 | 3.15 |
Vstm2a |
V-set and transmembrane domain containing 2A |
25 |
0.98 |
chr17_88325380_88326352 | 3.15 |
Gm22542 |
predicted gene, 22542 |
16616 |
0.17 |
chr14_68083721_68083923 | 3.13 |
Nefl |
neurofilament, light polypeptide |
41 |
0.97 |
chr15_16728489_16728641 | 3.13 |
Cdh9 |
cadherin 9 |
191 |
0.97 |
chr2_47334535_47334687 | 3.10 |
Gm25959 |
predicted gene, 25959 |
207373 |
0.03 |
chr13_73626497_73627526 | 3.10 |
Tert |
telomerase reverse transcriptase |
0 |
0.97 |
chr1_151427167_151427469 | 3.10 |
Swt1 |
SWT1 RNA endoribonuclease homolog (S. cerevisiae) |
1118 |
0.3 |
chr9_89827382_89827569 | 3.09 |
4930524O08Rik |
RIKEN cDNA 4930524O08 gene |
493 |
0.77 |
chr15_85458530_85458870 | 3.09 |
7530416G11Rik |
RIKEN cDNA 7530416G11 gene |
44527 |
0.13 |
chr1_42243123_42243275 | 3.08 |
Gm29664 |
predicted gene 29664 |
4504 |
0.21 |
chr2_126932364_126933545 | 3.08 |
Sppl2a |
signal peptide peptidase like 2A |
281 |
0.9 |
chr14_52012205_52012359 | 3.08 |
Zfp219 |
zinc finger protein 219 |
1400 |
0.2 |
chr19_15668305_15668530 | 3.08 |
Gm24319 |
predicted gene, 24319 |
11587 |
0.3 |
chr19_26770137_26770516 | 3.08 |
Smarca2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
165 |
0.96 |
chr14_66868293_66868444 | 3.07 |
Dpysl2 |
dihydropyrimidinase-like 2 |
320 |
0.61 |
chr12_49383638_49384096 | 3.06 |
Foxg1 |
forkhead box G1 |
860 |
0.39 |
chr5_65131292_65131908 | 3.06 |
Klhl5 |
kelch-like 5 |
71 |
0.97 |
chr3_45376075_45376524 | 3.06 |
2610316D01Rik |
RIKEN cDNA 2610316D01 gene |
1906 |
0.26 |
chr4_124035183_124035559 | 3.06 |
Gm12902 |
predicted gene 12902 |
109137 |
0.05 |
chr17_49966436_49966609 | 3.05 |
AC133946.1 |
oxidoreductase NAD-binding domain containing 1 (OXNAD1) pseudogene |
6305 |
0.22 |
chr6_127497123_127497327 | 3.05 |
Gm43633 |
predicted gene 43633 |
11432 |
0.17 |
chr3_88832410_88832792 | 3.05 |
1500004A13Rik |
RIKEN cDNA 1500004A13 gene |
54 |
0.95 |
chr3_7366262_7366434 | 3.04 |
Pkia |
protein kinase inhibitor, alpha |
321 |
0.92 |
chr3_34649198_34650117 | 3.03 |
Sox2 |
SRY (sex determining region Y)-box 2 |
748 |
0.5 |
chr8_54975886_54976217 | 3.02 |
Gm45263 |
predicted gene 45263 |
16232 |
0.14 |
chr13_8995529_8996265 | 3.02 |
Gtpbp4 |
GTP binding protein 4 |
153 |
0.91 |
chr13_69992009_69992203 | 3.02 |
Gm47655 |
predicted gene, 47655 |
15508 |
0.15 |
chr5_35907951_35908424 | 3.02 |
Afap1 |
actin filament associated protein 1 |
4895 |
0.22 |
chr3_101212393_101212761 | 3.01 |
Gm12486 |
predicted gene 12486 |
5178 |
0.18 |
chr9_90490658_90490809 | 3.01 |
Gm22866 |
predicted gene, 22866 |
138738 |
0.04 |
chr6_85502936_85503307 | 3.00 |
Fbxo41 |
F-box protein 41 |
127 |
0.94 |
chr4_94978559_94979517 | 3.00 |
Mysm1 |
myb-like, SWIRM and MPN domains 1 |
4 |
0.67 |
chr18_68943476_68943635 | 3.00 |
4930546C10Rik |
RIKEN cDNA 4930546C10 gene |
6586 |
0.28 |
chr16_42255688_42256016 | 2.99 |
Gap43 |
growth associated protein 43 |
20220 |
0.2 |
chr5_75410603_75410759 | 2.99 |
Gm42800 |
predicted gene 42800 |
11309 |
0.21 |
chr12_44337938_44338345 | 2.99 |
Nrcam |
neuronal cell adhesion molecule |
8891 |
0.18 |
chr10_89434934_89435106 | 2.98 |
Gas2l3 |
growth arrest-specific 2 like 3 |
242 |
0.95 |
chr4_142342527_142342678 | 2.98 |
Gm13052 |
predicted gene 13052 |
3873 |
0.33 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 11.7 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
1.8 | 5.4 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.6 | 3.1 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
1.5 | 6.2 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.5 | 10.8 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
1.4 | 4.1 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
1.3 | 3.9 | GO:0021564 | vagus nerve development(GO:0021564) |
1.2 | 3.7 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.2 | 4.9 | GO:0061743 | motor learning(GO:0061743) |
1.2 | 3.6 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
1.2 | 5.9 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
1.2 | 3.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
1.1 | 1.1 | GO:1901629 | regulation of presynaptic membrane organization(GO:1901629) |
1.1 | 5.3 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
1.0 | 3.1 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.0 | 9.1 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.9 | 5.6 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.9 | 2.6 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.9 | 0.9 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.8 | 3.3 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.8 | 3.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.8 | 3.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.8 | 1.6 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.8 | 3.2 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.8 | 2.4 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.8 | 8.6 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.8 | 2.3 | GO:0030070 | insulin processing(GO:0030070) |
0.8 | 3.8 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.8 | 1.5 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.7 | 7.5 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.7 | 3.0 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.7 | 3.0 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.7 | 3.0 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.7 | 3.0 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.7 | 2.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.7 | 2.2 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.7 | 1.4 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.7 | 2.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.7 | 1.4 | GO:0048880 | sensory system development(GO:0048880) |
0.7 | 1.4 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.7 | 2.1 | GO:0030242 | pexophagy(GO:0030242) |
0.7 | 2.1 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.7 | 2.8 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.7 | 1.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.7 | 2.1 | GO:0061511 | centriole elongation(GO:0061511) |
0.7 | 1.4 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.7 | 2.0 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.7 | 2.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.7 | 2.0 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.7 | 4.6 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.7 | 2.0 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.6 | 3.9 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.6 | 0.6 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.6 | 0.6 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.6 | 1.8 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.6 | 2.4 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.6 | 1.8 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.6 | 2.4 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.6 | 1.8 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.6 | 1.8 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.6 | 2.3 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.6 | 0.6 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
0.6 | 1.2 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.6 | 1.7 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.6 | 1.7 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.6 | 2.3 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.6 | 1.7 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.6 | 1.7 | GO:0097503 | sialylation(GO:0097503) |
0.6 | 1.7 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.6 | 0.6 | GO:1902992 | negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
0.6 | 1.7 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.5 | 2.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.5 | 4.3 | GO:0050957 | equilibrioception(GO:0050957) |
0.5 | 2.2 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.5 | 1.6 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.5 | 1.6 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.5 | 2.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.5 | 3.2 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.5 | 2.6 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
0.5 | 1.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.5 | 3.7 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.5 | 3.1 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.5 | 1.5 | GO:0021824 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
0.5 | 1.5 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.5 | 1.0 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.5 | 1.5 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.5 | 3.0 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.5 | 2.5 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.5 | 4.0 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.5 | 1.0 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.5 | 4.8 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.5 | 1.4 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.5 | 1.9 | GO:1902003 | regulation of beta-amyloid formation(GO:1902003) |
0.5 | 1.9 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.5 | 1.9 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.5 | 1.4 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.5 | 3.7 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.5 | 2.8 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.5 | 1.4 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.5 | 4.1 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.4 | 0.9 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.4 | 1.8 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.4 | 1.8 | GO:0007412 | axon target recognition(GO:0007412) |
0.4 | 1.3 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.4 | 0.9 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.4 | 1.3 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.4 | 1.3 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.4 | 2.2 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.4 | 1.3 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.4 | 0.9 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.4 | 1.3 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.4 | 0.9 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.4 | 1.7 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.4 | 0.4 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.4 | 1.3 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.4 | 0.4 | GO:0031223 | auditory behavior(GO:0031223) |
0.4 | 1.7 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.4 | 1.7 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.4 | 1.7 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.4 | 0.8 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.4 | 1.6 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.4 | 2.5 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.4 | 1.2 | GO:0072578 | neurotransmitter-gated ion channel clustering(GO:0072578) gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.4 | 0.4 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.4 | 1.2 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.4 | 1.2 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.4 | 0.4 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.4 | 0.8 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.4 | 0.4 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.4 | 3.2 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.4 | 1.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.4 | 4.2 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.4 | 1.9 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.4 | 2.2 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.4 | 4.4 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.4 | 2.9 | GO:0016264 | gap junction assembly(GO:0016264) |
0.4 | 1.8 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.4 | 1.1 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.4 | 1.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.4 | 1.4 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.4 | 1.1 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.4 | 2.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.3 | 1.0 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.3 | 1.0 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.3 | 1.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.3 | 0.7 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.3 | 1.4 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.3 | 0.7 | GO:0021544 | subpallium development(GO:0021544) |
0.3 | 0.7 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.3 | 1.0 | GO:0046881 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.3 | 0.7 | GO:0098597 | observational learning(GO:0098597) |
0.3 | 5.1 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.3 | 0.7 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.3 | 5.0 | GO:0010842 | retina layer formation(GO:0010842) |
0.3 | 1.0 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.3 | 1.0 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.3 | 1.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.3 | 1.0 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.3 | 0.3 | GO:0043465 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
0.3 | 2.6 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.3 | 1.0 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.3 | 1.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.3 | 0.3 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.3 | 0.6 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.3 | 1.0 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 0.3 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.3 | 1.9 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.3 | 1.8 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.3 | 0.6 | GO:1903367 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.3 | 0.6 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.3 | 0.9 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.3 | 0.3 | GO:0008038 | neuron recognition(GO:0008038) |
0.3 | 2.7 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.3 | 1.2 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.3 | 0.9 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.3 | 1.2 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.3 | 1.5 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.3 | 0.9 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.3 | 0.6 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.3 | 1.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.3 | 0.6 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.3 | 0.9 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.3 | 0.6 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.3 | 6.5 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.3 | 1.1 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.3 | 1.6 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.3 | 0.5 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.3 | 3.3 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.3 | 0.8 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.3 | 0.8 | GO:0090427 | activation of meiosis(GO:0090427) |
0.3 | 2.4 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.3 | 0.5 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.3 | 1.1 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.3 | 0.5 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.3 | 0.3 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.3 | 1.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 0.8 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.3 | 1.6 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.3 | 0.5 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.3 | 0.3 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.3 | 1.3 | GO:0022038 | corpus callosum development(GO:0022038) |
0.3 | 0.5 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.3 | 0.8 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.3 | 0.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.3 | 0.8 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.3 | 3.6 | GO:0060384 | innervation(GO:0060384) |
0.3 | 3.1 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.3 | 0.8 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.3 | 0.8 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.3 | 0.8 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.3 | 0.5 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.3 | 1.0 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.3 | 1.0 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.3 | 0.8 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.3 | 1.0 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.2 | 1.5 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.2 | 0.5 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.2 | 4.2 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.2 | 0.7 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.2 | 3.7 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.2 | 6.8 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.2 | 0.7 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.2 | 0.5 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.2 | 1.0 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.2 | 2.2 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 1.0 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.2 | 2.2 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.2 | 0.5 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.2 | 2.6 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.2 | 1.7 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.2 | 1.4 | GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
0.2 | 0.5 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.2 | 1.6 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.2 | 1.9 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.2 | 2.1 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.2 | 0.9 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.2 | 1.4 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.2 | 1.6 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.2 | 1.8 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 0.5 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.2 | 0.9 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.2 | 0.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 0.5 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.2 | 2.0 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 2.0 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.2 | 1.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.2 | 0.9 | GO:0030432 | peristalsis(GO:0030432) |
0.2 | 0.4 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.2 | 0.7 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.2 | 1.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.2 | 10.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.2 | 1.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 0.4 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.2 | 0.9 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.2 | 1.5 | GO:0007625 | grooming behavior(GO:0007625) |
0.2 | 0.9 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.2 | 1.1 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.2 | 0.9 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.2 | 0.6 | GO:0031296 | B cell costimulation(GO:0031296) |
0.2 | 0.8 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.2 | 4.4 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.2 | 0.4 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.2 | 1.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 0.4 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 0.2 | GO:1902566 | regulation of eosinophil degranulation(GO:0043309) regulation of eosinophil activation(GO:1902566) |
0.2 | 0.8 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.2 | 1.0 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 1.0 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.2 | 0.6 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 0.4 | GO:0051795 | positive regulation of catagen(GO:0051795) |
0.2 | 0.2 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.2 | 2.7 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.2 | 4.3 | GO:0007616 | long-term memory(GO:0007616) |
0.2 | 0.6 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.2 | 0.8 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.2 | 0.8 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.2 | 14.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 | 1.4 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 0.8 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.2 | 2.4 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.2 | 0.8 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 1.8 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.2 | 1.0 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 0.6 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.2 | 0.4 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.2 | 0.8 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 0.6 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.2 | 0.6 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.2 | 0.2 | GO:0097049 | motor neuron apoptotic process(GO:0097049) |
0.2 | 0.2 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.2 | 0.6 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.2 | 0.2 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.2 | 0.9 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.2 | 0.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.2 | 3.4 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.2 | 0.5 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.2 | 0.9 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.2 | 0.9 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.2 | 0.4 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.2 | 0.5 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 0.5 | GO:0060437 | lung growth(GO:0060437) |
0.2 | 0.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 1.7 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.2 | 0.2 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.2 | 0.5 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.2 | 1.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 1.0 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.2 | 1.4 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 1.7 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.2 | 0.3 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.2 | 0.7 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.2 | 0.2 | GO:0072553 | terminal button organization(GO:0072553) |
0.2 | 0.5 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.2 | 0.2 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.2 | 0.3 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.2 | 2.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 0.2 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.2 | 0.3 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.2 | 0.7 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 0.7 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 0.7 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.2 | 0.8 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.2 | 1.0 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.2 | 0.5 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
0.2 | 0.5 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 0.2 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.2 | 1.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 0.5 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 0.6 | GO:0022605 | oogenesis stage(GO:0022605) |
0.2 | 0.8 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 0.6 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.2 | 1.4 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.2 | 1.3 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.2 | 1.0 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.2 | 0.6 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 0.9 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 0.5 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.2 | 0.3 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.2 | 0.5 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 1.1 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.2 | 0.3 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.2 | 1.2 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.2 | 0.6 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.2 | 0.2 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.2 | 0.5 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.2 | 0.8 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.2 | 1.2 | GO:0001964 | startle response(GO:0001964) |
0.1 | 0.3 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.6 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 0.4 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.1 | 0.4 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.1 | 0.3 | GO:0051305 | meiotic chromosome movement towards spindle pole(GO:0016344) chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.4 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.6 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.1 | 0.4 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.7 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 0.1 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.4 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.9 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.1 | 0.6 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.1 | 0.3 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.1 | 1.0 | GO:0001975 | response to amphetamine(GO:0001975) |
0.1 | 0.4 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.1 | 1.0 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.9 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 0.1 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.1 | 0.7 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 1.1 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.1 | 0.7 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.1 | 0.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.7 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 0.3 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 1.9 | GO:0007416 | synapse assembly(GO:0007416) |
0.1 | 0.6 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.1 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.1 | 0.5 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.4 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.1 | 0.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.9 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.4 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.1 | 0.5 | GO:1904666 | regulation of ubiquitin protein ligase activity(GO:1904666) positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 0.1 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 0.7 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 1.1 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.1 | 0.3 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.1 | 0.5 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.7 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.4 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 1.1 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.1 | 0.4 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 1.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.3 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.6 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.1 | 3.3 | GO:0008542 | visual learning(GO:0008542) |
0.1 | 0.4 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.1 | 0.5 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.1 | 0.3 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.1 | 0.3 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.1 | 0.5 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.5 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.4 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 0.1 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.1 | 0.8 | GO:0034776 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.1 | 0.4 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.1 | 0.5 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.1 | 0.5 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 1.4 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.4 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.2 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 1.0 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.5 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.1 | 0.2 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.1 | 0.2 | GO:0072093 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.1 | 0.1 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.1 | 0.1 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.1 | 0.6 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.4 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.1 | 0.1 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.1 | 0.1 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.1 | 0.4 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.5 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 1.7 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.6 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.1 | 0.8 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 1.9 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 | 1.5 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.1 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.1 | 0.4 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.1 | 0.1 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.1 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.1 | 0.3 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.1 | 0.7 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.1 | 0.6 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.1 | 0.7 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.1 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.3 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.5 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.2 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 0.2 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.1 | 0.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.6 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.3 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.1 | 0.4 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.2 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.1 | 0.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.4 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.4 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.2 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.1 | 0.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.1 | 1.1 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.4 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 0.1 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.1 | 0.1 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.1 | 1.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.2 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.1 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.1 | 0.2 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.3 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 0.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.6 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 1.9 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.6 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.1 | 0.1 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.1 | 0.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 0.5 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.2 | GO:0051031 | tRNA transport(GO:0051031) |
0.1 | 0.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.4 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.4 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.2 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.1 | 0.3 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 0.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 0.3 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.1 | 0.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.1 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.1 | 1.4 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.6 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.3 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.1 | 0.5 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 0.2 | GO:0071051 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) U4 snRNA 3'-end processing(GO:0034475) polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.1 | 0.5 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.1 | 0.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.5 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.1 | 0.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.3 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 1.5 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.8 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 0.3 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.3 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.3 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 0.5 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.1 | 0.1 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.1 | 0.6 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.2 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.2 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.1 | 0.2 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.1 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.5 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.1 | 0.4 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.5 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.1 | 1.8 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.2 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.1 | 0.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 0.3 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 1.1 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.4 | GO:0032305 | positive regulation of icosanoid secretion(GO:0032305) |
0.1 | 0.3 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 1.7 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.2 | GO:0002890 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.1 | 0.1 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.1 | 0.2 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.1 | 0.4 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.3 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.1 | 0.3 | GO:0060013 | righting reflex(GO:0060013) |
0.1 | 0.3 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.1 | 0.2 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 0.3 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.5 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.1 | 0.3 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 0.3 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.1 | 0.3 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.1 | 0.3 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 1.9 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 1.2 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 0.7 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.1 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.1 | 0.1 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.1 | 0.2 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.1 | 0.2 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.1 | 0.1 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.1 | 0.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.3 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.1 | 0.6 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.8 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 1.0 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 0.4 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.1 | 0.6 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.2 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.7 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.3 | GO:0001810 | regulation of type I hypersensitivity(GO:0001810) type I hypersensitivity(GO:0016068) |
0.1 | 0.6 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.8 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.1 | 5.9 | GO:0098792 | xenophagy(GO:0098792) |
0.1 | 0.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.3 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 0.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.3 | GO:0086005 | ventricular cardiac muscle cell action potential(GO:0086005) |
0.1 | 0.1 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.1 | 1.9 | GO:0001895 | retina homeostasis(GO:0001895) |
0.1 | 0.4 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.1 | 0.2 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.1 | 0.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 1.1 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.1 | 0.4 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.1 | 0.2 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.1 | 0.2 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 0.1 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) positive regulation of glucose mediated signaling pathway(GO:1902661) |
0.1 | 0.2 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.3 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 0.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 0.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 1.0 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 1.4 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.1 | 0.4 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.1 | GO:0030576 | Cajal body organization(GO:0030576) |
0.1 | 0.4 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.3 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 4.1 | GO:0099643 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.1 | 0.7 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.6 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.1 | 0.2 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.1 | 0.1 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 0.1 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.1 | 0.4 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.1 | GO:0014891 | striated muscle atrophy(GO:0014891) |
0.1 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.2 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.1 | 0.1 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.1 | 0.3 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 2.2 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.1 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.9 | GO:0042558 | pteridine-containing compound metabolic process(GO:0042558) |
0.1 | 0.1 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.1 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 0.1 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.2 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.4 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.3 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.3 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.5 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.1 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.1 | 0.3 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.3 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.7 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.1 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.1 | 0.4 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.1 | 0.1 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.1 | 1.0 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 2.1 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 0.3 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.2 | GO:0060004 | reflex(GO:0060004) |
0.1 | 0.7 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 1.0 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.1 | 0.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 6.1 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.1 | 0.4 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.2 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.1 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.1 | 0.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 0.9 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 1.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.1 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.1 | 0.4 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.6 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.2 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.2 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 0.2 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.1 | 0.1 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.1 | 0.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.2 | GO:0042161 | lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.1 | 0.3 | GO:0032616 | interleukin-13 production(GO:0032616) |
0.1 | 0.1 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.1 | 0.3 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.1 | 0.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.1 | 0.1 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 0.2 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.2 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.1 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 0.2 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.1 | 0.3 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 0.1 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.1 | 0.1 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.1 | 0.3 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.1 | 0.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.1 | 0.2 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.1 | 0.1 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
0.1 | 0.1 | GO:0000726 | non-recombinational repair(GO:0000726) |
0.1 | 0.3 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 0.3 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.3 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.2 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.1 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.1 | 0.5 | GO:0090102 | cochlea development(GO:0090102) |
0.1 | 0.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.5 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.1 | 0.2 | GO:0072178 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.1 | 0.1 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.1 | 0.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.2 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.0 | 0.1 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.0 | 0.6 | GO:0045954 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.0 | 0.1 | GO:0030878 | thyroid gland development(GO:0030878) |
0.0 | 0.1 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.0 | 0.0 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.2 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.0 | 0.0 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.0 | 0.1 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.1 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.0 | 0.1 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 0.8 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.0 | 0.5 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.0 | 0.2 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.0 | 0.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 1.1 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.7 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.0 | 0.1 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.0 | 0.5 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.1 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.0 | 0.0 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.0 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.0 | 0.1 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.0 | 0.3 | GO:0048665 | neuron fate specification(GO:0048665) |
0.0 | 0.2 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.0 | 0.3 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.0 | 0.0 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.0 | 0.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.0 | 0.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.1 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.0 | 0.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.2 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.1 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.0 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.1 | GO:0021826 | substrate-independent telencephalic tangential migration(GO:0021826) interneuron migration from the subpallium to the cortex(GO:0021830) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
0.0 | 0.0 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.0 | 0.1 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.0 | 0.0 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.2 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.0 | 0.3 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.2 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.0 | 0.1 | GO:1904181 | positive regulation of membrane depolarization(GO:1904181) |
0.0 | 0.1 | GO:0015867 | ATP transport(GO:0015867) |
0.0 | 0.1 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.0 | 0.0 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.0 | 0.0 | GO:0046036 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.0 | 0.0 | GO:0018214 | protein carboxylation(GO:0018214) |
0.0 | 0.0 | GO:0090169 | regulation of spindle assembly(GO:0090169) |
0.0 | 0.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.4 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.0 | 0.5 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.5 | GO:0032094 | response to food(GO:0032094) |
0.0 | 0.2 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.0 | 0.2 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 0.1 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.0 | 0.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 0.0 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.0 | 0.1 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.0 | 0.4 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.0 | 0.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.0 | 0.0 | GO:0032536 | regulation of cell projection size(GO:0032536) |
0.0 | 0.1 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.0 | 0.0 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.0 | 0.1 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.0 | 0.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 0.1 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.0 | 0.3 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 1.8 | GO:0048017 | inositol lipid-mediated signaling(GO:0048017) |
0.0 | 1.0 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.2 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.0 | 0.3 | GO:0048753 | pigment granule organization(GO:0048753) |
0.0 | 0.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.1 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.0 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.2 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.0 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.0 | 0.1 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.0 | 0.1 | GO:0002254 | kinin cascade(GO:0002254) |
0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.0 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.0 | 0.0 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.0 | 0.3 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.7 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.0 | 0.5 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.0 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.0 | 0.1 | GO:0002934 | desmosome organization(GO:0002934) |
0.0 | 0.1 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 0.1 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.0 | 0.3 | GO:0031102 | neuron projection regeneration(GO:0031102) |
0.0 | 0.1 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.0 | 0.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.3 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.0 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.0 | 0.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.0 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.0 | 0.1 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.1 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.0 | 0.1 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.0 | GO:0072079 | nephron tubule formation(GO:0072079) |
0.0 | 0.0 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.0 | 0.2 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.1 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 1.1 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.1 | GO:0033023 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.0 | 0.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.0 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.0 | 0.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 0.1 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.0 | 0.3 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.0 | 0.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.0 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.0 | 0.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.1 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.1 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.0 | 0.0 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.0 | 0.1 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.1 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.0 | 0.0 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.0 | 0.0 | GO:0002215 | defense response to nematode(GO:0002215) |
0.0 | 0.1 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.0 | 0.0 | GO:2001140 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.0 | 0.0 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.0 | 0.1 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.0 | 0.2 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.0 | 0.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.0 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.0 | 0.5 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
0.0 | 0.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.0 | 0.1 | GO:0090189 | regulation of branching involved in ureteric bud morphogenesis(GO:0090189) |
0.0 | 0.0 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.1 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.1 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.0 | 0.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.0 | GO:0046958 | nonassociative learning(GO:0046958) |
0.0 | 0.2 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.0 | GO:1900376 | regulation of melanin biosynthetic process(GO:0048021) regulation of secondary metabolite biosynthetic process(GO:1900376) |
0.0 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.0 | GO:0060459 | left lung development(GO:0060459) |
0.0 | 0.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.1 | GO:0015879 | carnitine transport(GO:0015879) |
0.0 | 0.0 | GO:0006868 | glutamine transport(GO:0006868) |
0.0 | 0.0 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
0.0 | 0.1 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.0 | 0.1 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.1 | GO:0006531 | aspartate metabolic process(GO:0006531) |
0.0 | 0.0 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.0 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.0 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) |
0.0 | 0.0 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.0 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.0 | 0.1 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.0 | 0.5 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.0 | GO:0038107 | determination of left/right asymmetry in lateral mesoderm(GO:0003140) nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.0 | 0.3 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.0 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.0 | 0.0 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.0 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.0 | 0.0 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.0 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 0.1 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.0 | 0.0 | GO:0042048 | olfactory behavior(GO:0042048) |
0.0 | 0.0 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.1 | GO:0007530 | sex determination(GO:0007530) |
0.0 | 0.0 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
0.0 | 0.0 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.0 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.1 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.0 | 0.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.0 | 0.0 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.0 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.0 | 0.0 | GO:0072501 | cellular divalent inorganic anion homeostasis(GO:0072501) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.0 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.0 | 0.3 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.0 | 0.0 | GO:0021675 | nerve development(GO:0021675) |
0.0 | 0.2 | GO:0006379 | mRNA cleavage(GO:0006379) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.2 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
1.3 | 4.0 | GO:0097441 | basilar dendrite(GO:0097441) |
0.9 | 8.9 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.8 | 2.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.8 | 8.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.8 | 2.4 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.8 | 3.8 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.7 | 2.9 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.7 | 2.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.7 | 2.8 | GO:0070545 | PeBoW complex(GO:0070545) |
0.7 | 2.1 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.7 | 2.7 | GO:0033010 | paranodal junction(GO:0033010) |
0.7 | 5.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.6 | 3.7 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.6 | 2.4 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.6 | 1.7 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.5 | 2.1 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.5 | 3.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 4.6 | GO:0036156 | inner dynein arm(GO:0036156) |
0.5 | 1.0 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.5 | 2.0 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.5 | 2.0 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.5 | 23.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.5 | 2.8 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.5 | 1.8 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.4 | 2.7 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.4 | 2.7 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.4 | 0.4 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.4 | 5.3 | GO:0071564 | npBAF complex(GO:0071564) |
0.4 | 1.3 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.4 | 2.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.4 | 1.3 | GO:0072534 | perineuronal net(GO:0072534) |
0.4 | 1.6 | GO:1990246 | uniplex complex(GO:1990246) |
0.4 | 1.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.4 | 0.8 | GO:0032280 | symmetric synapse(GO:0032280) |
0.4 | 2.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.4 | 17.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.4 | 1.5 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.3 | 0.7 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.3 | 2.3 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.3 | 1.0 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.3 | 0.9 | GO:0042585 | germinal vesicle(GO:0042585) |
0.3 | 3.7 | GO:0097440 | apical dendrite(GO:0097440) |
0.3 | 2.5 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 1.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.3 | 1.4 | GO:0000235 | astral microtubule(GO:0000235) |
0.3 | 1.6 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.3 | 8.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.3 | 1.6 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.3 | 4.7 | GO:0044295 | axonal growth cone(GO:0044295) |
0.3 | 1.8 | GO:0016272 | prefoldin complex(GO:0016272) |
0.3 | 2.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.3 | 1.8 | GO:0033263 | CORVET complex(GO:0033263) |
0.3 | 2.9 | GO:0043194 | axon initial segment(GO:0043194) |
0.3 | 0.8 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.3 | 2.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 0.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.2 | 3.9 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 1.5 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.2 | 1.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 1.0 | GO:0033269 | internode region of axon(GO:0033269) |
0.2 | 1.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.2 | 1.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 0.9 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 0.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 1.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 1.6 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 12.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 0.7 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 1.0 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 1.6 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.2 | 3.0 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 0.8 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 0.6 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 0.6 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 0.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 0.9 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 4.5 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 2.1 | GO:0032590 | dendrite membrane(GO:0032590) |
0.2 | 11.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 0.7 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.2 | 3.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.2 | 2.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 0.5 | GO:0043511 | inhibin complex(GO:0043511) |
0.2 | 1.0 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 1.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 0.3 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 2.4 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 22.8 | GO:0060076 | excitatory synapse(GO:0060076) |
0.2 | 2.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 0.5 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.2 | 4.1 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.2 | 0.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 1.9 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 0.9 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 0.5 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 1.5 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.1 | 1.1 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 0.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 0.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 1.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 14.9 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 1.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 1.8 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 1.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 4.0 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 1.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.4 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 0.4 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 0.6 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 1.0 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 0.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.1 | 1.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 8.5 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 1.3 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 1.4 | GO:0097060 | synaptic membrane(GO:0097060) |
0.1 | 1.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 4.2 | GO:0098794 | postsynapse(GO:0098794) |
0.1 | 0.2 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.2 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 0.3 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.7 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 1.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.5 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.9 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 0.4 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.7 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.9 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.8 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.4 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 0.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 1.2 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.3 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.5 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.3 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.3 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 0.6 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.4 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 0.3 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 1.0 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 1.2 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.1 | 0.3 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 2.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.6 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 1.9 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 1.0 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 3.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.3 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.2 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 0.2 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 0.2 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 6.6 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.5 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 2.0 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.6 | GO:0071012 | U2-type catalytic step 1 spliceosome(GO:0071006) catalytic step 1 spliceosome(GO:0071012) |
0.1 | 0.2 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.1 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 0.5 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 4.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 7.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 1.4 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 0.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.5 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.6 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.3 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.5 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 1.0 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.4 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 2.0 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 0.2 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.2 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 1.5 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.2 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.1 | 0.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.0 | 0.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 0.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 1.7 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.0 | 1.1 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.0 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 0.2 | GO:0035363 | histone locus body(GO:0035363) |
0.0 | 0.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.8 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.4 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 3.0 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.2 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.9 | GO:0042611 | MHC protein complex(GO:0042611) |
0.0 | 0.4 | GO:0071010 | prespliceosome(GO:0071010) |
0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.0 | 0.1 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.0 | 0.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 1.0 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.7 | GO:0070469 | respiratory chain(GO:0070469) |
0.0 | 0.1 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.0 | 0.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.1 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.0 | 0.0 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 0.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 1.0 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.0 | 0.1 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.0 | 0.1 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.1 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.0 | 0.1 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.0 | 0.0 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.0 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.0 | GO:1990130 | Iml1 complex(GO:1990130) |
0.0 | 0.0 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 9.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.2 | 6.7 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.5 | 7.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.2 | 3.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.1 | 4.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.1 | 5.4 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.0 | 3.0 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.9 | 1.9 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.9 | 4.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.9 | 1.8 | GO:0070905 | serine binding(GO:0070905) |
0.9 | 2.6 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.8 | 7.3 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.7 | 3.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.7 | 3.0 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.7 | 0.7 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.7 | 2.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.7 | 2.1 | GO:0035939 | microsatellite binding(GO:0035939) |
0.7 | 3.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.7 | 2.1 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.6 | 3.7 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.6 | 6.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.6 | 2.9 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.6 | 1.1 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.5 | 1.5 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.5 | 1.5 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.5 | 1.9 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.5 | 1.9 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.5 | 1.9 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.5 | 1.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.5 | 1.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.5 | 0.5 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.5 | 2.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.5 | 0.5 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.4 | 1.8 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.4 | 1.3 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.4 | 2.2 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.4 | 4.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.4 | 3.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.4 | 3.0 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.4 | 1.3 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.4 | 1.3 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.4 | 12.2 | GO:0045296 | cadherin binding(GO:0045296) |
0.4 | 6.2 | GO:0030955 | potassium ion binding(GO:0030955) |
0.4 | 0.4 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.4 | 0.8 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.4 | 0.4 | GO:0051378 | serotonin binding(GO:0051378) |
0.4 | 1.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.4 | 0.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 3.5 | GO:0070513 | death domain binding(GO:0070513) |
0.4 | 1.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.4 | 3.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.4 | 2.3 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.4 | 1.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.4 | 2.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.4 | 1.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.4 | 0.7 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.4 | 4.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 1.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.3 | 1.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.3 | 1.0 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.3 | 1.3 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.3 | 1.0 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.3 | 2.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.3 | 1.6 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.3 | 0.9 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.3 | 1.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.3 | 0.6 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.3 | 0.9 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.3 | 10.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.3 | 2.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.3 | 0.9 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.3 | 2.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.3 | 0.9 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.3 | 1.4 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.3 | 5.5 | GO:0022824 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.3 | 3.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 0.8 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.3 | 0.8 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.3 | 1.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.3 | 2.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.3 | 0.8 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.3 | 1.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.3 | 6.1 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.3 | 3.4 | GO:0035198 | miRNA binding(GO:0035198) |
0.3 | 1.3 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.3 | 0.5 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.3 | 2.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.3 | 0.8 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.3 | 1.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.3 | 2.5 | GO:0022821 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
0.3 | 1.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.3 | 0.8 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.2 | 2.0 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 3.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 1.0 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 1.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 2.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 0.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 1.7 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 7.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.2 | 3.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 1.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 0.5 | GO:0048763 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
0.2 | 1.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 0.7 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.2 | 1.8 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.2 | 1.3 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.2 | 0.7 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.2 | 1.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 1.3 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.2 | 1.3 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.2 | 0.6 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.2 | 1.9 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 0.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 1.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 1.1 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.2 | 0.6 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.2 | 2.5 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.2 | 0.8 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.2 | 0.8 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.2 | 0.6 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 0.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.2 | 0.8 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 0.8 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.2 | 1.8 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.2 | 1.4 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 0.8 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) calcium:cation antiporter activity(GO:0015368) |
0.2 | 0.2 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.2 | 2.6 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 1.2 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.2 | 0.8 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.2 | 0.6 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.2 | 0.8 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.2 | 0.8 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.2 | 1.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 1.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 0.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.2 | 0.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 0.9 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.2 | 0.2 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.2 | 3.7 | GO:0004118 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.2 | 0.7 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 1.3 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.2 | 2.0 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 2.0 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.2 | 1.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.9 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 0.2 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 0.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.2 | 0.5 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 0.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.2 | 2.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 3.6 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.2 | 1.0 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 0.8 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 0.8 | GO:0016151 | nickel cation binding(GO:0016151) |
0.2 | 0.7 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.2 | 0.5 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 0.7 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 0.8 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.2 | 0.8 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 0.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 0.8 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.2 | 1.4 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.2 | 3.5 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.2 | 0.6 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.2 | 1.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 0.6 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 3.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 4.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.7 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.7 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 1.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.9 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 3.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 2.0 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 1.1 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.1 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.8 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.4 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.1 | 0.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.5 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.1 | 0.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 1.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.1 | 0.3 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.1 | 0.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.5 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 2.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.7 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.2 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 2.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.7 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 4.3 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 1.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.2 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 1.3 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.1 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.3 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.6 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.1 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.1 | 0.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.3 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.1 | 0.2 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.1 | 1.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.4 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 1.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.1 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.1 | 1.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 1.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 1.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.4 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 0.2 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.1 | 0.8 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.1 | 0.2 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 0.6 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 0.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 1.0 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 0.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.1 | 0.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.4 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.1 | 0.6 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 1.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 1.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 1.2 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.4 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 2.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.4 | GO:0052760 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.1 | 0.8 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.9 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.3 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 1.9 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 2.1 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 0.3 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 0.4 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.4 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 0.2 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 2.9 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 1.1 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.1 | 1.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.7 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.5 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 0.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.7 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 1.0 | GO:0036222 | XTP diphosphatase activity(GO:0036222) |
0.1 | 0.2 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 0.2 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.1 | 0.2 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 0.4 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.1 | 0.9 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.4 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 0.8 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.4 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.7 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.6 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 4.7 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 0.5 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.3 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.1 | 0.4 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 0.4 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 1.5 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.3 | GO:0015298 | solute:cation antiporter activity(GO:0015298) |
0.1 | 0.7 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 0.7 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.5 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 1.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 1.7 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 1.3 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 0.3 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.1 | 0.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.2 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 1.7 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 0.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.3 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 1.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.1 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.1 | 0.4 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.1 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.1 | 0.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 5.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 0.2 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.1 | 0.6 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.2 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.2 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 0.9 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.5 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 0.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.6 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 0.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 0.4 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.3 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 1.5 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 3.9 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.3 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.2 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.2 | GO:0097001 | ceramide binding(GO:0097001) |
0.0 | 0.3 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 0.0 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 1.0 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 1.1 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.0 | 5.0 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.2 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.0 | 0.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.0 | 0.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.4 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.4 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 3.3 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.5 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 1.1 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.9 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.0 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.0 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.0 | 0.0 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.0 | 0.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.2 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 1.1 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.7 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.3 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.3 | GO:0022840 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.0 | 0.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.0 | 0.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.0 | 0.0 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 1.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.0 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.0 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.6 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.0 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.0 | 0.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.2 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.3 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.0 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.0 | 0.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.0 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.0 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.0 | 0.1 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.0 | 0.0 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.0 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.2 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.2 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.0 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.1 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.0 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.0 | 0.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.0 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 0.0 | GO:0045545 | syndecan binding(GO:0045545) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 0.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 4.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 0.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 0.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 1.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 3.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 5.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 3.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 2.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 1.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 4.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 2.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 3.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 2.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 5.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 1.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 0.9 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 2.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 2.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 2.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.6 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 2.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 2.6 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 0.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.6 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 0.8 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 0.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 0.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 1.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 1.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 1.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 2.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.8 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.3 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.7 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 6.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 3.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.4 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.0 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 9.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.5 | 3.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.5 | 1.5 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.5 | 0.5 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.5 | 3.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.5 | 6.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.5 | 10.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.4 | 4.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.4 | 1.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.4 | 4.1 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.3 | 4.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 0.9 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 0.6 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.3 | 4.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 3.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.3 | 2.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.3 | 2.9 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.3 | 2.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 3.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 3.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 0.7 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.2 | 2.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.2 | 2.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.2 | 0.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 6.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 3.1 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.2 | 9.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 2.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 0.6 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.2 | 0.4 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 0.4 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 2.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 9.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 2.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 3.7 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.2 | 1.7 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.2 | 4.0 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 1.9 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 2.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 2.9 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 3.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 4.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 1.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.2 | 1.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 1.8 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 1.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 0.8 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 3.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 0.5 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.2 | 1.5 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 0.7 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 0.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 1.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 2.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 1.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 0.7 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 2.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 2.3 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 0.9 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 1.7 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 0.5 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 0.1 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.1 | 1.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 3.0 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 2.9 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 1.0 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 1.2 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 2.1 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 0.1 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.4 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 1.7 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.9 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 0.7 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.1 | 0.9 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |
0.1 | 2.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 0.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 1.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.9 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 0.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 1.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.9 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 2.1 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.1 | 0.5 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 0.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 0.9 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 6.0 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 0.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.2 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.1 | 0.9 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 2.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 1.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.3 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.0 | 0.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.2 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.0 | 2.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.3 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.9 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.1 | REACTOME PLATELET HOMEOSTASIS | Genes involved in Platelet homeostasis |
0.0 | 0.5 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 0.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.4 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.0 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.1 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.0 | 0.0 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |